# Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis

> **NCT01130844** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 52 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** MMX Mesalamine
- **DRUG:** MMX Mesalamine
- **DRUG:** MMX Mesalamine

## Key facts

- **NCT ID:** NCT01130844
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-08
- **Primary completion:** 2013-06-27
- **Final completion:** 2013-06-27
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130844, "Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01130844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*